Monday 19 April 2021

Reuters Health Report: Exclusive-Abu Dhabi art gallery owner has a sideline business: trading COVID-19 vaccines

Exclusive-Abu Dhabi art gallery owner has a sideline business: trading COVID-19 vaccines

ABU DHABI (Reuters) -From a small office in an Abu Dhabi skyscraper, Ukrainian national Natalya Muzaleva and her Hungarian husband Istvan Perger run an art gallery, a real estate agency and an oilfield services company.

Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines

Resuming the use of Johnson & Johnson's COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be aware of the telltale symptoms, according to heart doctors and other medical experts.

Austria will only use Sputnik V vaccine after EMA approval, Kurz says

Austria will only use Russia's Sputnik V coronavirus vaccine once the European Medicines Agency has approved it, Chancellor Sebastian Kurz said on Monday, amid growing public frustration with the pace of COVID-19 vaccinations.

Factbox-Latest on the worldwide spread of the coronavirus

(Reuters) -More than 141.47 million people have been reported as having been infected by the novel coronavirus globally and 3,159,601​ have died, according to a Reuters tally.

Factbox-Some countries limit AstraZeneca vaccine use, U.S. pauses J&J shot

Some countries are restricting use of the AstraZeneca COVID-19 vaccine to certain age groups, or suspending use, after European and British regulators confirmed possible links to rare blood clots.

Factbox-Some countries limit AstraZeneca vaccine use, US pauses J&J shot

(Reuters) -Some countries are restricting use of the AstraZeneca COVID-19 vaccine to certain age groups, or suspending use, after European and British regulators confirmed possible links to rare blood clots.

India to fund capacity boost at Serum Institute as vaccines run short - source

NEW DELHI (Reuters) -India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupee ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.

J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic

Four drugmakers are set to face trial on Monday in a lawsuit by several large counties in California that are seeking more than $50 billion over claims the companies helped fuel an opioid epidemic by deceptively marketing addictive painkillers.

Spain mulls delaying second dose of Moderna and Pfizer shots, El Mundo reports

MADRID (Reuters) -Spain's Health Ministry is considering delaying second doses of COVID-19 vaccines for under 80 year olds to maximise the number of people who have received at least one injection, El Mundo newspaper reported on Monday, citing an official document.

What you need to know about the coronavirus right now

(Reuters) -Here's what you need to know about the coronavirus right now:

Delhi locks down as COVID chokes Indian health system

NEW DELHI (Reuters) -India's capital region of Delhi ordered a six-day lockdown on Monday as daily COVID-19 cases nationwide hit a new record and the health system crumbled under the weight of new infections.

Related Videos

Chile hails 'game-changer' Sinovac data

Frontline nurse receives note from Taylor Swift